The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

Analyst Mani Foroohar of Leerink Partners maintained a Sell rating on Moderna (MRNA – Research Report), reducing the price target to ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Berenberg Bank analyst Harry Gillis maintained a Hold rating on Moderna (MRNA – Research Report) yesterday and set a price target of $33.00.

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...